Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission

11Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: Two to seven percent of the German adult population has a renal impairment (RI) with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2. This often remains unrecognized and adjustment of drug therapy is lacking. To determine renal function in clinical routine, the CKD-EPI equation is used to calculate an indexed eGFR (ml/min/1.73m2). For drug dosing, it has to be individualized to a non-indexed eGFR (ml/min) by the patient’s body surface area. Here, we investigated the number of patients admitted to urological wards of a teaching hospital with RI between July and December 2016. Additionally, we correctly used the eGFRnon-indexed for drug and dosage adjustments and to analyse the use of renal risk drugs (RRD) and renal drug-related problems (rDRP). Methods: In a retrospective observational study, urological patients with pharmacist-led medication reconciliation at hospital admission and eGFRindexed (CKD-EPI) of 15–59 ml/min/1.73m2 were identified. Indexed eGFR (ml/min/1.73m2) was recalculated with body surface area to non-indexed eGFR (ml/min) for correct drug dosing. Medication at admission was reviewed for RRD and based on the eGFRnon-indexed for rDRP, e.g. inappropriate dose or contraindication. Results: Of 1320 screened patients, 270 (20.5%) presented with an eGFRindexed of 15–59 ml/min/1.73m2. After readjustment, 203 (15.4%) patients had an eGFRnon-indexed of 15–59 ml/min. Of these, 190 (93.6%) used ≥ 1 drugs at admission with 660 of 1209 (54.7%) drugs classified as RRD. At least one rDRP was identified in 115 (60.5%) patients concerning 264 (21.8%) drugs. Conclusion: Renal impairment is a common risk factor for medication safety in urologic patients admitted to a hospital. Considerable shifts were seen in eGFR-categories when correctly calculating eGFRnon-indexed for drug dosing purposes. The fact that more than half of the study patients showed rDRP at hospital admission underlines the need to consider this risk factor appropriately.

References Powered by Scopus

A new equation to estimate glomerular filtration rate

20736Citations
N/AReaders
Get full text

Prediction of creatinine clearance from serum creatinine

13931Citations
N/AReaders
Get full text

Simplified Calculation of Body-Surface Area

2686Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction

14Citations
N/AReaders
Get full text

Implementation of a renal pharmacist consultant service — Information sharing in paper versus digital form

5Citations
N/AReaders
Get full text

Inappropriate prescribing in patients with kidney disease: A rapid review of prevalence, associated clinical outcomes and impact of interventions

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Seiberth, S., Bauer, D., Schönermarck, U., Mannell, H., Stief, C., Hasford, J., & Strobach, D. (2020). Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission. European Journal of Clinical Pharmacology, 76(12), 1683–1693. https://doi.org/10.1007/s00228-020-02953-6

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

44%

Researcher 3

33%

Professor / Associate Prof. 1

11%

Lecturer / Post doc 1

11%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 9

69%

Medicine and Dentistry 3

23%

Neuroscience 1

8%

Save time finding and organizing research with Mendeley

Sign up for free